We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWAY
151
DELISTED
HOMEAWAY INC COM
AWAY
| $35.1M | 0.21% |
857,830
-47,440
| -5% | -$1.62M |
|
152
Masco
MAS
$15.2B
| $34.4M | 0.2% |
1,718,272
+211,304
| +14% | +$3.93M |
|
|
SCS
153
DELISTED
Steelcase
SCS
| $33.4M | 0.2% |
2,104,127
-105,800
| -5% | -$1.68M |
|
154
Enovis
ENOV
$1.78B
| $33.4M | 0.2% |
304,414
-20,318
| -6% | -$2.03M |
|
155
Wynn Resorts
WYNN
$10.1B
| $33M | 0.19% |
170,145
-38,015
| -18% | -$6.48M |
|
|
WWAV
156
DELISTED
The WhiteWave Foods Company
WWAV
| $32.8M | 0.19% |
1,430,219
-396,690
| -22% | -$8.25M |
|
|
TIF
157
DELISTED
Tiffany & Co.
TIF
| $32.7M | 0.19% |
352,970
+64,980
| +23% | +$5.4M |
|
158
Reinsurance Group of America
RGA
$15.5B
| $32.7M | 0.19% |
423,030
-13,750
| -3% | -$1M |
|
159
CoStar Group
CSGP
$12.1B
| $32.6M | 0.19% |
1,767,920
-377,250
| -18% | -$6.67M |
|
|
MWV
160
DELISTED
MEADWESTVACO CORP
MWV
| $31M | 0.18% |
839,050
+219,285
| +35% | +$7.91M |
|
161
Martin Marietta Materials
MLM
$33.4B
| $30.9M | 0.18% |
309,300
-7,210
| -2% | -$709K |
|
162
Madison Square Garden
MSGS
$9.51B
| $30.7M | 0.18% |
746,397
+74,334
| +11% | +$3.03M |
|
163
Jazz Pharmaceuticals
JAZZ
$16.4B
| $30.1M | 0.18% |
+238,195
| New | +$24.6M |
|
164
Akamai
AKAM
$17.9B
| $30M | 0.18% |
635,830
+140,895
| +28% | +$6.65M |
|
|
SF
165
Stifel
SF
$12.7B
| $29.9M | 0.18% |
1,404,518
-79,605
| -5% | -$1.53M |
|
166
Landstar System
LSTR
$6.16B
| $29.8M | 0.18% |
518,360
-578,535
| -53% | -$32.4M |
|
|
SPN
167
DELISTED
Superior Energy Services, Inc.
SPN
| $29.8M | 0.18% |
111,911
-6,556
| -6% | -$1.71M |
|
168
XPO
XPO
$23.8B
| $29.8M | 0.18% |
3,272,937
+525,829
| +19% | +$4.05M |
|
169
Regions Financial
RF
$27.3B
| $29.7M | 0.18% |
+3,006,000
| New | +$28.9M |
|
|
INVN
170
DELISTED
Invensense Inc
INVN
| $29.5M | 0.17% |
1,420,675
+589,845
| +71% | +$10.6M |
|
171
Steris
STE
$22.7B
| $29.5M | 0.17% |
613,446
-226,050
| -27% | -$10.3M |
|
|
BIN
172
DELISTED
PROGRESSIVE WASTE SOLUTIONS LTD COM
BIN
| $29.2M | 0.17% |
1,181,104
-71,640
| -6% | -$1.85M |
|
|
TMHC
173
DELISTED
Taylor Morrison
TMHC
| $28.4M | 0.17% |
1,264,272
-408,718
| -24% | -$8.8M |
|
174
Viavi Solutions
VIAV
$9.95B
| $28.1M | 0.17% |
+3,810,412
| New | +$28.9M |
|
175
Dollar General
DG
$28.1B
| $27.9M | 0.16% |
463,105
-13,690
| -3% | -$804K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.